GN

Gopal Nand Jha

Active Director Director DIN 03245055
DIN 03245055 First appointment Nov 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2010
Shareholding value •••• Premium profile

About Gopal Nand Jha

Data last updated:

Gopal Nand Jha is a Director at Palbik Pharma Private Limited (since 2010). The company operates in Trading. Palbik Pharma Private Limited reported revenue of ₹3.33 Cr (FY 2025).

DIN 03245055
Primary Designation Director
Industry Trading
First Appointment 03 Nov 2010
Oldest Company Age 15 yrs
Largest company Palbik Pharma Private Limited · ₹3.33 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Palbik Pharma Private Limited U51909JH2010PTC014481
Director03 Nov 20102010₹3.33 Cr (FY 2025)Active

Board colleagues of Gopal Nand Jha

Directorship timeline

Open interactive timeline →
Palbik Pharma Private Limited
Premium access

Shareholding and investment profile for Gopal Nand Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopal Nand Jha

Gopal Nand Jha currently holds 1 directorship: Palbik Pharma Private Limited (Director, since 03 Nov 2010, revenue ₹3.33 Cr (FY 2025)).

Gopal Nand Jha was first appointed on 03 Nov 2010 as Director at Palbik Pharma Private Limited.

The current boards of Gopal Nand Jha's companies include Bhushan Sahay (Palbik Pharma Private Limited), Bikash Kumar Singh (Palbik Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available